Category:

Health

Latest

Overall COVID-19 seropositivity among healthcare workers over 25 per cent: minister

The Indian Council of Medical Research is undertaking periodic sero-surveillance to monitor the trend of COVID-19 infection. As per the third seroprevalence study (December 2020 to January 2021) results the overall COVID-19 seropositivity among healthcare workers is assessed to be 25.7 per cent,” he said in a written reply. Seroprevalence is highest among doctors and nurses (26.6 per cent), followed by para-medical staff (25.4 per cent), field staff (25.3 per cent) and administrative staff (24.9 per cent), Choubey said in a written reply.

read more

WHO says coronavirus unlikely to have leaked from China lab

The WHO team’s mission is intended to be an initial step delving into the origins of the virus, which is believed to have originated in bats before being passed to humans through another species of wild animal, such as a pangolin or bamboo rat, which is considered an exotic delicacy by some in China.

Transmission through the trade in frozen products was also a possibility, WHO food safety and animal diseases expert Peter Ben Embarek said.

read more

EU antitrust regulators halt Aon, Willis probe, await data

The European Commission, which kicked off its probe in December because of concerns the deal to create the world’s largest insurance broker may hurt competition in major markets, said it stopped the clock on Monday.

“This procedure in merger investigations is activated if the parties fail to provide, in a timely fashion, an important piece of information that the Commission has requested from them,” a spokeswoman for the EU competition enforcer said.

read more

A few Covid vaccine recipients developed a rare blood disorder

It is not known whether this blood disorder is related to the Covid vaccines.

More than 31 million people in the United States have received at least one dose, and 36 similar cases had been reported to the government’s Vaccine Adverse Event Reporting System, VAERS, by the end of January. The cases involved either the Pfizer-BioNTech or Moderna vaccine, the only two authorized so far for emergency use in the United States.

read more

Astrazeneca gets nod to use ant-diabetes drug for kidney disease in India

“Despite currently available therapies, a significant unmet need for effective management of CKD continues to exist globally. With the approval of dapagliflozin for CKD in India, an already effective type-2 diabetes and select heart failure treatment, can now be used by nephrologists in the management of CKD,” AstraZeneca India Vice President – Medical Affairs and Regulatory Anil Kukreja said.

read more